Processa Pharmaceuticals (PCSA) Competitors $0.46 -0.02 (-3.56%) As of 03:46 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends PCSA vs. NLSP, VAXX, BGXX, CANF, HOTH, DWTX, FRTX, SNGX, EVOK, and GLTOShould you be buying Processa Pharmaceuticals stock or one of its competitors? The main competitors of Processa Pharmaceuticals include NLS Pharmaceutics (NLSP), Vaxxinity (VAXX), Bright Green (BGXX), Can-Fite BioPharma (CANF), Hoth Therapeutics (HOTH), Dogwood Therapeutics (DWTX), Fresh Tracks Therapeutics (FRTX), Soligenix (SNGX), Evoke Pharma (EVOK), and Galecto (GLTO). These companies are all part of the "pharmaceutical products" industry. Processa Pharmaceuticals vs. NLS Pharmaceutics Vaxxinity Bright Green Can-Fite BioPharma Hoth Therapeutics Dogwood Therapeutics Fresh Tracks Therapeutics Soligenix Evoke Pharma Galecto Processa Pharmaceuticals (NASDAQ:PCSA) and NLS Pharmaceutics (NASDAQ:NLSP) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, media sentiment, earnings, risk, analyst recommendations, dividends, valuation and community ranking. Which has better earnings and valuation, PCSA or NLSP? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProcessa PharmaceuticalsN/AN/A-$11.12M-$3.39-0.14NLS PharmaceuticsN/AN/A-$12.17MN/AN/A Do institutionals and insiders believe in PCSA or NLSP? 91.9% of Processa Pharmaceuticals shares are held by institutional investors. 13.0% of Processa Pharmaceuticals shares are held by insiders. Comparatively, 16.4% of NLS Pharmaceutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in PCSA or NLSP? Processa Pharmaceuticals received 7 more outperform votes than NLS Pharmaceutics when rated by MarketBeat users. Likewise, 60.00% of users gave Processa Pharmaceuticals an outperform vote while only 57.14% of users gave NLS Pharmaceutics an outperform vote. CompanyUnderperformOutperformProcessa PharmaceuticalsOutperform Votes1560.00% Underperform Votes1040.00% NLS PharmaceuticsOutperform Votes857.14% Underperform Votes642.86% Is PCSA or NLSP more profitable? NLS Pharmaceutics' return on equity of 0.00% beat Processa Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Processa PharmaceuticalsN/A -195.21% -163.06% NLS Pharmaceutics N/A N/A N/A Do analysts recommend PCSA or NLSP? Processa Pharmaceuticals presently has a consensus price target of $6.00, indicating a potential upside of 1,204.35%. Given Processa Pharmaceuticals' stronger consensus rating and higher probable upside, research analysts plainly believe Processa Pharmaceuticals is more favorable than NLS Pharmaceutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Processa Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00NLS Pharmaceutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk & volatility, PCSA or NLSP? Processa Pharmaceuticals has a beta of 0.75, indicating that its stock price is 25% less volatile than the S&P 500. Comparatively, NLS Pharmaceutics has a beta of -0.3, indicating that its stock price is 130% less volatile than the S&P 500. Does the media favor PCSA or NLSP? In the previous week, NLS Pharmaceutics had 1 more articles in the media than Processa Pharmaceuticals. MarketBeat recorded 1 mentions for NLS Pharmaceutics and 0 mentions for Processa Pharmaceuticals. Processa Pharmaceuticals' average media sentiment score of 0.00 equaled NLS Pharmaceutics'average media sentiment score. Company Overall Sentiment Processa Pharmaceuticals Neutral NLS Pharmaceutics Neutral SummaryProcessa Pharmaceuticals beats NLS Pharmaceutics on 8 of the 12 factors compared between the two stocks. Remove Ads Get Processa Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PCSA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PCSA vs. The Competition Export to ExcelMetricProcessa PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.50M$7.06B$5.69B$8.07BDividend YieldN/A2.72%4.89%4.02%P/E Ratio-0.146.2624.9119.04Price / SalesN/A219.61382.71118.19Price / CashN/A65.6738.0534.62Price / Book0.116.526.884.22Net Income-$11.12M$139.99M$3.19B$246.59M7 Day Performance-5.74%0.67%-0.44%-1.43%1 Month Performance-26.49%-6.32%-6.54%-8.59%1 Year Performance-79.82%-8.89%9.06%0.51% Processa Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PCSAProcessa Pharmaceuticals3.3875 of 5 stars$0.46-3.6%$6.00+1,204.3%-79.0%$1.50MN/A-0.1420NLSPNLS PharmaceuticsN/A$1.78-3.3%N/A+401.5%$6.40MN/A0.006VAXXVaxxinityN/A$0.05+49,900.0%N/A-92.8%$6.34MN/A-0.1190Gap DownBGXXBright GreenN/A$0.03-3.2%N/A-78.1%$6.31MN/A-0.552CANFCan-Fite BioPharma1.8289 of 5 stars$1.72-2.3%$14.00+714.0%-30.8%$6.09M$667,000.00-0.968HOTHHoth Therapeutics3.1854 of 5 stars$0.87-5.0%$4.00+359.8%-15.4%$6.01MN/A-0.664Analyst ForecastNews CoveragePositive NewsGap UpDWTXDogwood TherapeuticsN/A$4.29-10.4%N/AN/A$5.71MN/A-0.655News CoverageFRTXFresh Tracks TherapeuticsN/A$0.94-0.5%N/A+2.5%$5.59M$10.06M-0.6620SNGXSoligenix1.3683 of 5 stars$2.20-4.8%N/A-81.6%$5.52M$840,000.00-0.2920EVOKEvoke Pharma0.5031 of 5 stars$3.62-22.3%N/A-54.5%$5.38M$8.62M-0.334News CoverageGap UpHigh Trading VolumeGLTOGalecto2.4349 of 5 stars$4.01-8.4%$10.00+149.4%-81.4%$5.28MN/A-0.2140 Remove Ads Related Companies and Tools Related Companies NLS Pharmaceutics Alternatives Vaxxinity Alternatives Bright Green Alternatives Can-Fite BioPharma Alternatives Hoth Therapeutics Alternatives Dogwood Therapeutics Alternatives Fresh Tracks Therapeutics Alternatives Soligenix Alternatives Evoke Pharma Alternatives Galecto Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PCSA) was last updated on 3/11/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Processa Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Processa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
